Skip to content

Direct Transfer to an Endovascular Center Compared to Transfer to the Closest Stroke Center in Acute Stroke Patients With Suspected Large Vessel Occlusion

A Trial Comparing Transfer to the Closest Local Stroke Center vs. Direct Transfer to Endovascular Stroke Center of Acute Stroke Patients With Suspected Large Vessel Occlusion in the Catalan Territory.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02795962
Acronym
RACECAT
Enrollment
1401
Registered
2016-06-10
Start date
2017-03-01
Completion date
2020-10-01
Last updated
2021-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Endovascular Procedures, Emergency Medical Services

Brief summary

To evaluate the hypothesis that direct transfer to an Endovascular Stroke Center, compared to transfer to the closest Local Stroke Center, offers a better outcome in the distribution of the modified Rankin Scale scores at 90 days in acute ischemic stroke patients with clinically suspected Large Vessel Occlusion identified by Emergency Medical Services (EMS).

Detailed description

Prospective, multicenter, cluster randomized controlled, usual care conditions, open, blinded-endpoint trial of acute stroke patients with suspected acute large vessel occlusion (LVO) identified by EMS at first assistance on the field, in which two strategies will be compared: transfer to the closest local stroke center (Local-SC) Vs. direct transfer to an endovascular stroke center (EVT-SC). The RACE scale (Rapid Arterial oCclusion Evaluation) will be used as a prehospital screening tool to identify acute stroke patients with suspicion of LVO. Upon candidate identification, EMS will contact a stroke neurologist on call using a prehospital telestroke system who will confirm inclusion criteria and will allocate the subjects to a specific intervention according to a pre-established temporal sequence. Allocation will account for 3 strata: time band (two groups of 12 hours), territory (metropolitan versus provincial area) and week day (working versus weekend day). Subjects will be followed up to 90 days post-randomization.

Interventions

OTHERDirect transfer to an Endovascular Center

Cluster randomized controlled study: allocation to active or no intervention arm will be performed accordingly to a pre-established temporal sequence

Sponsors

Medtronic
CollaboratorINDUSTRY
Anagram-ESIC
CollaboratorUNKNOWN
UPC
CollaboratorUNKNOWN
BioClever 2005 S.L.
CollaboratorOTHER
Fundacio Ictus Malaltia Vascular
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Suspected LVO acute stroke patients identified by a RACE scale score \>4 at the pre-hospital setting, that is evaluated by EMS professionals when attending patients, in non-stroke ready centers or primary health centers, previous to the transfer to a stroke center. * Patients located in geographical areas in which the reference stroke center is a hospital not capable to offer endovascular treatment (Primary stroke Center or Telestroke Center). * Estimated arrival time at an EVT-SC \<7 hours from symptom onset. Symptom onset is defined as point in time the patient was last seen well (at baseline). * No significant pre-stroke functional disability (modified Rankin scale 0 - 2) * Age ≥18 * Deferred informed consent obtained from patient or acceptable patient surrogate (after the acute phase, as permission to use clinical data within a clinical registry)

Exclusion criteria

* Patients in a coma (NIHSS item of consciousness \>1) * Patients with unstable clinical status who require emergent life support care * Serious, advanced, or terminal illness with anticipated life expectancy of less than 6 month. * Suspected LVO acute stroke patients identified at the Emergency Department of a stroke center * Subject participating in a study involving an investigational drug or device that would impact this study. * Patients with a pre-existing neurological or psychiatric disease that would confound the neurological or functional evaluations. This excludes patients who are severely demented, require constant assistance in a nursing home type setting or who live at home but are not fully independent in activities of daily living (toileting, dressing, eating, cooking and preparing meals, etc.) * Unlikely to be available for 90-day follow-up (e.g. no fixed home address, visitor from overseas).

Design outcomes

Primary

MeasureTime frameDescription
modified Rankin Scale score (shift analysis)90 daysModified Rankin Scale score in ischemic stroke patients as evaluated through a structured telephone-based interview performed by a central assessor who is blinded to group assignment.

Secondary

MeasureTime frameDescription
Mortality in hemorrhagic stroke patients90 daysMortality in hemorrhagic stroke patients
Clinical deterioration requiring orotracheal intubation during transfers8 hoursOrotracheal intubation during transfers
Clinical deterioration24 hoursClinical deterioration (≥4 points on the NIHSS)
Reperfusion therapies8 hoursProportion of patients receiving iv tPA and endovascular treatment within the first 8h from symptom onset
Mortality in all patients90 daysMortality in all patients included
Subgroup analysis90 daysDistribution of the modified Rankin Scale score at 90 days (shift analysis) in the following subgroups: * Ischemic / hemorrhagic * Patients eligible for iv t-PA vs. non iv t-PA eligible when attended by EMS (within time window considering transfer time to the nearest SC, no formal contraindications as recent major surgery or anticoagulation) * Patients treated with EVT
Clinical benefit of direct vs. local transfer accordingly with time and distance to the Endovascular Center90 daysTo analyze whether an inflection point exists with respect to time from onset to arrival at the Endovascular Center beyond which transfer to a Local-SC is beneficial or equivalent.
Dramatic early favorable response24 (-2/+12 hours)Dramatic early favorable response as determined by an NIHSS (National Institute of Health Stroke Scale) of 0-2 or NIHSS improvement ≥ 8 points in ischemic stroke and hemorrhagic stroke patients.
Time from symptom onset to reperfusion therapies8 hoursTime from symptom onset to iv tPA administration (for patients treated with iv tPA) and to groin puncture (for patients treated with endovascular).

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026